NCT04543669View on ClinicalTrials.gov

Adacel® Booster Vaccination for CMI Assay Development

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 12, 2017

Primary Completion Date

September 20, 2017

Study Completion Date

September 20, 2017

Conditions
Pertussis
Interventions
BIOLOGICAL

Adacel®

Vaccine for TdaP-Tetanus, diphtheria, acellular pertussis

Trial Locations (1)

B3K 6R8

Canadian Center for Vaccinology, Halifax

All Listed Sponsors
collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

collaborator

VaxDesign Corporation

UNKNOWN

lead

Dalhousie University

OTHER

NCT04543669 - Adacel® Booster Vaccination for CMI Assay Development | Biotech Hunter | Biotech Hunter